Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
3.8K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

746
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
746
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Emergent RNA targets in cardiovascular disease: likely candidates for treatment development.

Expert opinion on therapeutic targets·2026
Same author

Hypoxia-driven microRNA-27b underlies pathologic cardiac endoreplication in heart disease.

Signal transduction and targeted therapy·2026
Same author

Neuroendocrine Carcinoma of the Submandibular Gland in an Older Adult: A Rare Case and Literature Review.

The American journal of case reports·2026
Same author

Charting individualized pathways: IGF-1 and vitamin D in guiding personalized medicine for residual risk after AMI.

Progress in cardiovascular diseases·2026
Same author

Interleukin 11-Induced MicroRNAs as Functional Mediators and Circulating Biomarkers of Cardiac Fibrosis.

Circulation research·2026

Related Experiment Video

Updated: Mar 19, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

8.0K

Long noncoding RNA dysregulation in ischemic heart failure.

Simona Greco1, Germana Zaccagnini1, Alessandra Perfetti1

  • 1IRCCS Policlinico San Donato, Via Morandi, 30, 20097, San Donato Milanese, Milan, Italy.

Journal of Translational Medicine
|June 19, 2016
PubMed
Summary

Long noncoding RNAs (lncRNAs) are implicated in heart failure. This study identified a signature of deregulated lncRNAs in patients, with some showing potential as biomarkers for heart disease.

More Related Videos

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
07:54

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion

Published on: August 29, 2018

9.1K
Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart
05:54

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart

Published on: February 3, 2023

2.8K

Related Experiment Videos

Last Updated: Mar 19, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

8.0K
Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
07:54

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion

Published on: August 29, 2018

9.1K
Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart
05:54

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart

Published on: February 3, 2023

2.8K

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiovascular Research

Background:

  • Long noncoding RNAs (lncRNAs) regulate physiological and pathological processes.
  • The role of lncRNAs in heart failure (HF) remains largely unexplored.
  • This study investigates lncRNA deregulation in ischemic heart failure.

Purpose of the Study:

  • Identify and characterize lncRNAs dysregulated in ischemic heart failure patients.
  • Establish a lncRNA signature associated with heart failure.
  • Explore the potential of specific lncRNAs as biomarkers for heart failure.

Main Methods:

  • Profiling and validation of lncRNAs in human heart biopsies from non-end-stage and end-stage heart failure patients.
  • Analysis of lncRNA expression in a mouse model of cardiac hypertrophy.
  • Assessment of lncRNA distribution in cardiac tissue using in situ hybridization.
  • Correlation analysis of lncRNA expression with neighboring mRNAs and gene ontology analysis.

Main Results:

  • A signature of fourteen significantly modulated lncRNAs was identified in non-end-stage heart failure.
  • Nine key lncRNAs, including H19, HOTAIR, and RMRP, were confirmed in end-stage failing hearts and a mouse hypertrophy model.
  • Specific lncRNAs (CDKN2B-AS1/ANRIL, HOTAIR, LOC285194/TUSC7) showed similar expression patterns in blood and heart tissue, indicating potential biomarker utility.
  • Functional analysis revealed associations between lncRNAs and pathways involved in heart failure progression.

Conclusions:

  • Long noncoding RNAs play a significant role in the molecular mechanisms of heart failure.
  • The identified lncRNA signature offers insights into heart failure pathogenesis.
  • Certain lncRNAs may serve as valuable biomarkers for diagnosing and monitoring heart failure.